Member Announcements 2009

December 21, 2009

Response Biomedical Receives Further U.S. Patent and Trademark
Office Notice of Allowance for Key Patent
 

 

December 17, 2009

Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study
 

 

December 11, 2009

iCo Therapeutics Provides Phase 1 Diabetic Macular Edema (DME) Clinical Trial Update and Phase 2 Trial Guidance
 

 

December 9, 2009

Sirius Genomics Announces Change in Leadership
 

 

December 8, 2009

Sirona Biochem Says Improved Chemical Process For Its Sugar Blocker Molecules Will Speed up Pre-Clinical Development
 

 

December 7, 2009

SIRONA BIOCHEM BOLSTERS SCIENTIFIC ADVISORY BOARD WITH ANOTHER TOP CANADIAN SCIENTIST.
 

 

December 7, 2009

Genome BC collaborates with Chile and Norway to sequence salmon genome
 

 

December 1, 2009

Statement: World Aids Day – Working Together
 

 

December 1, 2009

CDRD Appoints Karimah Es Sabar as Senior Vice President, Business and Strategic Affairs
 

 

November 23, 2009

Eminent Canadian Diabetes Scientist Joins Sirona Biochem’s Scientific Advisory Board
 

 

November 23, 2009

Inimex Announces Appointment of New CEO
 

 

November 17, 2009

Sirona Biochem Says New Results From Big Pharma Shows Why SGLT2 Sugar Blockers Are a Major Opportunity in Fighting Diabetes
 

 

November 17, 2009

Welichem announces 2009 AGM Board members election and management changes
 

 

November 17, 2009

World Courier Pioneers GxP-Compliant Status Worldwide
 

 

November 16, 2009

Genomics to provide more effective treatment options for mining wastewater
 

 

November 9, 2009

BC Cancer Agency to lead $1.3-million program evaluating medical-isotope alternatives
 

 

November 5, 2009

One of Canada’s Leading Obesity Scientists Joins Sirona Biochem’s Scientific Advisory Board
 

 

November 5, 2009

Biolux Research Announces Financing and Investigational Testing Authorization for the Development of a Light Accelerated Orthodontics Product
 

 

November 3, 2009

One of Canada’s Leading Biotech Pioneers Joins Sirona Biochem’s Scientific Advisory Board
 

 

October 27, 2009

EnWave to Test Animal Vaccines with Saskatchewan Research Council Using freezeREV Pharmaceutical Dehydration Technology
 

 

October 27, 2009

QLT Announces Share Repurchase Program
 

 

October 23, 2009

Angiotech Pharmaceuticals Announces Commercial Launch of the Tan Endoglideâ„¢ Endothelium Insertion System in the United States at the American Academy of Ophthalmology Annual Meeting
 

 

October 22, 2009

Response Biomedical Obtains Special 510(k) U.S. FDA Clearance to Add Analytical Reactivity Information for the 2009 H1N1 Influenza A Virus to the RAMP ® Influenza A/B Assay Package Insert
 

 

October 22, 2009

Simon Fraser University: New technology revolutionizes cancer research
 

 

October 21, 2009

Board Changes at WEX
 

 

October 20, 2009

Xenon and CDRD’s Commercial Arm, DDI, Announce Strategic R&D Collaboration
 

 

October 20, 2009

iCo Therapeutics Announces $4,000,000 Brokered Private Placement

 

 

October 19, 2009

Maxxam Analytics acquires CANTEST, BC’s leading independent analytical laboratory
 

 

October 15, 2009

New hands-on science exhibition excites bright young minds
 

 

October 13, 2009

Sirona Biochem Says New Obesity Data Shows It’s on the Right Path
 

 

October 9, 2009

OncoGenex Pharmaceuticals CEO Named Canada’s Pacific Ernst & Young’s Entrepreneur Of The Year(R) in the Health Sciences Category
 

 

October 8, 2009

STEMCELL Technologies Inc. Introduces MethoCult ® Express for Cord Blood Banks and Transplant Centers
 

 

October 7, 2009

Major breast cancer breakthrough announced at BC Cancer Agency
 

 

October 2, 2009

Zymeworks Appoints Computational Antibody Design Expert Dr. Bruce Tidor to its Scientific Advisory Board
 

 

September 29, 2009

Sirona Biochem Adds French Patenting ‘Top Gun’ Lawyer to its Scientific Advisory Board
 

 

September 24, 2009

Genomic research will help provide alternative treatments to patients with iron overload
 

 

September 24, 2009

iCo Therapeutics Signs Collaboration Agreement with The Consortium for Parasitic Drug Development
 

 

September 24, 2009

Construction starts on new research centre
 

 

September 22, 2009

Sirona Biochem to ‘Accelerate’ Drug Development After French Partner Opens State-of-the-Art Lab
 

 

September 14, 2009

Sirona Biiochem Says SGLT Test Results Confirm Key ‘Breakthrough’
 

 

September 10, 2009

Lignol Awarded $4.72 Million in Funding from SDTC
 

 

September 9, 2009

Genomics sciences guarantee better results in the art of winemaking
 

 

September 9, 2009

Heart Force Medical Inc. Appoints Chief Business Officer
 

 

September 8, 2009

NEW FACILITY TO TRAIN HUNDREDS MORE PHARMACISTS FOR BC
 

 

September 8, 2009

World’s Top Scientists Arriving This Weekend for World Congress on Huntington Disease
 

 

September 4, 2009

BC Bioenergy Network Provides $1,180,000 Support to Lignol Innovations Ltd. for Lignin Research Collaboration Project
 

 

August 24, 2009

Two genomic research projects to tackle supply and demand issues in emerging forestry biofuels industry
 

 

August 21, 2009

iCo Therapeutics Q2 2009 Financial Results
 

 

 

August 19, 2009

CANTEST wins 3-year Contract with Manitoba Water Stewardship
 

 

 

August 13, 2009

Sirona Biochem Recieves Financial Contribution From NRC-IRAP
 

 

August 13, 2009

Biolux Research Announces Support from the National Research Council of Canada Industrial Research Assistance Program for the Development of Light Accelerated Orthodontics Product
 

 

August 10, 2009

Cardiome Announces Management Transition
 

 

August 10, 2009

OncoGenex Pharmaceuticals Announces Issuance of Key Patent for OGX-011
 

 

July 31, 2009

Pacgen Reports Fiscal 2009 Financial Results
 

 

July 30, 2009

Heart Force Receives USFDA Certification for dBG 300 Digital Ballistocardiograph
 

 

July 29, 2009

Response Biomedical Receives U.S. FDA 510(k) Market Clearance of Rapid Respiratory Syncytial Virus Test
 

 

July 28, 2009

Cardiome achieves milestone from collaboration with Merck & Co., Inc.
 

 

July 28, 2009

Sirona Biochem Starts Testing First Batch of Drug Candidates Designed to Combat Diabetes and Obesity
 

 

July 27, 2009

OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering
 

 

July 27, 2009

Connect ’09: Driving Technology Commercialization in BC, BC Innovation Council Accepting Submissions for Awards
 

 

July 16, 2009

Sirona Biochem Optimizes Key Test for Diabetes and Obesity Drug Development
 

 

July 16, 2009

New Chair Appointed to BC Hydro Board
 

 

July 15, 2009

New BIOTECanada Survey Finds Almost 7,000 High Skilled Science Jobs to be Lost
 

 

July 9, 2009

Allon Releases Results of Phase II Schizophrenia Cognitive Impairment Clinical Trial
 

 

July 8, 2009

Goldbeck Recruiting Inc. Announces Successful Launch of Life Sciences Division
 

 

July 7, 2009

iCo Therapeutics Diabetic Macular Edema Clinical Trial Update
 

 

July 2, 2009

iCo Therapeutics Publishes Review of Diabetic Retinopathy Treatment
 

 

July 1, 2009

CombinatoRx and Neuromed Sign Merger Agreement
 

 

June 26, 2009

Biolux Research Announces OsseoPulseâ„¢ Production Milestone and Expanding Distribution
 

 

June 25, 2009

iCo Therapeutics Positive Oral Amphotericin B Data Published in the Journal of Infectious Diseases
 

 

June 23, 2009

Zymeworks Closes $3.5 Million Round of Financing and Announces Changes to its Board of Directors
 

 

June 17, 2009

Four outstanding Canadian teachers and schools receive $10,000 each – Amgen Award for Science Teaching Excellence
 

 

June 17, 2009

Neuromed Announces Sale of U.S. Rights to Drug Candidate Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) to Mallinckrodt
 

 

June 12, 2009

Lignol Announces Production of Cellulosic Ethanol from New Biorefinery Pilot Plant
 

 

June 12, 2009

Xenon Enters Cardiovascular Disease Collaboration with Merck & Co., Inc.
 

 

June 10, 2009

Victoria Tech Leader Appointed Head of UVic Properties
 

 

June 10, 2009

enGene Inc. receives NRC-IRAP contribution, initiates Convertible Note financing
 

 

June 9, 2009

Sirona Biochem Appoints a Leading Biotech Scientist to Progress its Diabetes and Obesity Drug Discovery Program
 

 

June 9, 2009

New Development Fund to Accelerate Commercialization of Genomics-related Drug Discoveries
 

 

June 8, 2009

Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
 

 

June 8, 2009

Drug Developers Convene in Vancouver to Explore new Approaches to Commercializing Promising Medicines
 

 

June 3, 2009

Scientists in BC set to receive $2.7 million in funding
 

 

June 3, 2009

Starfish Medical Receives Team of the Year at VIATeC Awards Night
 

June 3, 2009

Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation
 

 

June 2, 2009

QLT announces positive results from the evaluation of Visudyne(R) combination therapy
 

 

June 1, 2009

Urodynamix Technologies Ltd. Reports Fiscal 2009 First Quarter Results
 

 

May 30, 2009

OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial
 

 

May 27, 2009

Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system
 

 

May 26, 2009

Researchers devising blood test to diagnose organ rejection in transplant patients
 

 

May 15, 2009

Zymeworks and XOMA to Collaborate on Antibody Research Program
 

 

May 15, 2009

ASKA Research and CNS Become the First Companies to Sign Strategic Partnership Agreement as Part of the Intergovernmental Economic Research Agreement
 

 

May 13, 2009

Centre for Drug Research and Development CEO Wins National Award for Biotech Industry Leadership
 

 

May 13, 2009

Zymeworks Awarded BIOTECanada’s Gold Leaf Award as Early Stage Company of the Year
 

 

May 11, 2009

Angiotech and Boston Scientific welcome journal article noting important differences between drug-eluting stent brands
 

 

May 7, 2009

Response Biomedical Announces Terms of Unit Offering
 

 

May 5, 2009

Canadian biotech faces time of reckoning: Ernst & Young
 

 

May 1, 2009

BC Bioenergy Network Contributes to UBC Clean Energy Research Centre To Advance Bioenergy Research
 

 

May 1, 2009

Canada’s First Public Biotech Company since 2007 is launched to help combat the “twin epidemics” – Diabetes and Obesity.
 

 

April 30, 2009

BC Advantage Completes Redemption of Advantage Life Sciences Fund I
 

 

April 30, 2009

Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009
 

 

April 29, 2009

Sirona Biochem Corp. Management Team Restructuring: Mark Senner appointed to President, Christopher Hopton to Chief Financial Officer and John Dougherty to Corporate Development
 

 

April 28, 2009

MDS Nordion and TRIUMF Collaborate to Study Development of Photo Fission-Produced Molybdenum-99
 

 

April 28, 2009

Pacgen to Acquire Xphase Pharmaceuticals
 

 

April 28, 2009

OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer
 

 

April 27, 2009

WEX to Present at BioFinance 2009 Conference
 

 

April 24, 2009

Angiotech announces date of annual general meeting of shareholders
 

 

April 23, 2009

ASKA Research and Clinical Development Solutions Enter Into Strategic Partnership Agreement to Enhance Canadian Clinical Trial Infrastructure
 

 

April 23, 2009

BC Liberals Commit to HIV/AIDS Pilot Project
 

 

April 20, 2009

Patients to Benefit From New Vision Treatments
 

 

April 20, 2009

Canada urgently needs to reinvest in the life sciences industry: PwC and BIOTECanada survey
 

 

April 20, 2009

Welichem announces IND-enabling toxicology studies for its lead drug, WBI-1001
 

 

April 20, 2009

Government of Canada and Genome Canada Invest in Applied Genomics Research to Strengthen Canada’s Agriculture, Crop and Bioproduct Sectors
 

 

April 20, 2009

Sirona Biochem Corp. announces the final completion of its Qualifying Transaction (“QT”) with TFChem S.A.R.L.
 

 

April 15, 2009

Cardiome hits potential $1B home run
 

 

April 14, 2009

Zymeworks Appoints Antibody and Drug Development Expert Dr. Paul J. Carter to its Scientific Advisory Board
 

 

April 14, 2009

Angiotech Pharmaceuticals, Inc. – New study shows that Zilver(R) PTX(TM) effectively treats blockages in critical thigh artery
 

 

April 14, 2009

Tekmira Pharmaceuticals Files IND for ApoB SNALP
 

 

April 10, 2009

Grade 12 student wins award for alzheimers work
 

 

April 9, 2009

OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
 

 

April 8, 2009

Merck & Co., Inc. and Cardiome Sign License Agreement for Vernakalant, an Investigational Drug for Treatment of Atrial Fibrillation
 

 

April 7, 2009

Canadian Bioenergy and ADM enter into negotiations to build canola biodiesel facility
 

 

April 3, 2009

Tekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial in Patients With Liver Cancer -First Clinical Trial Utilizing SNALP Triggers Milestone Payment-
 

 

March 31, 2009

Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc
 

 

March 30, 2009

BC’s Health Research Community Gets Booster Shot
 

 

March 30, 2009

Indel Therapeutics Aims High With New Class of Antibiotics to Fight Hospital Infections
 

 

March 30, 2009

Ondine Biopharma Announces 2008 Year End Financial Results
 

 

March 30, 2009

Neovasc to Raise $2 Million in Non-Brokered Private Placement
 

 

March 30, 2009

Okanagan Research & Innovation Centre (ORIC) Officially Opens in Kelowna
 

 

March 26, 2009

QLT names Kathryn Falberg to the board of directors
 

 

March 25, 2009

Tekmira Pharmaceuticals Extends Research Collaboration with Bristol-Myers Squibb through 2009
 

 

March 24, 2009

HONEYWELL’S UOP AND ENSYN LAUNCH ENVERGENT TECHNOLOGIES TO OFFER SECOND-GENERATION BIOMASS TECHNOLOGY
 

 

March 24, 2009

B.C. HIRES INDIA TRADE & INVESTMENT REPRESENTATIVE
 

 

March 23, 2009

iCo Therapeutics Oral Anti-Parasitic Drug to be Presented at Global Health Symposia

VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) announced today that results from the company’s anti-fungal and anti-parasitic oral Amphotericin B program, “iCo-009”, will be presented at a Bill & Melinda Gates Foundation sponsored event in Breckenridge, Colorado.

 

March 23, 2009

Neuromed Announces Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial
 

 

March 23, 2009

Merck Serono Launches Strategic Venture Capital Fund
 

 

March 20, 2009

$15-MILLION DONATION LAUNCHES RESEARCH CENTRE AT VGH
 

 

March 20, 2009

WEX Appoints Vice President, Research and Development
 

 

March 19, 2009

Lignol Project Awarded $1.82 Million in Additional Funding from SDTC
 

 

March 18, 2009

Biolux Research Announces European Launch of the OsseoPulseâ„¢ Bone Regeneration System
 

 

March 18, 2009

Fish Research Nets Awards
 

March 17, 2009

iCo Therapeutics iCo-007 Second Cohort Results to be Presented at Cleveland Clinic Ocular Conference

VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce that preliminary results for the first two cohorts from the ongoing clinical trial for iCo’s Diabetic Macular Edema (DME) candidate, iCo-007, will be featured in a presentation at an important ocular conference.

 

March 17, 2009

Pyng Medical Corp. Announces Election of Directors at 2009 Annual General Meeting and Executive Restructuring
 

March 16, 2009

Government of Canada Announces New Ocean Research Centre in Victoria
 

 

March 12, 2009

Ovarian cancer not just one disease: Study
 

 

March 9, 2009

LifeSciences BC Announces Recipients of the 2009 LifeSciences British Columbia Awards
 

 

March 9, 2009

Angiotech announces positive results from Bio-Seal(TM) clinical study
 

 

March 9, 2009

Nexterra Energy wins 2009 Life Sciences British Columbia Company of the Year Award for Bioenergy
 

 

March 9, 2009

Response Biomedical Named Medical Device Company of the Year by LifeSciences British Columbia
 

 

March 9, 2009

Allon Reports 2008 Audited Operating Results and Updates 2009 Plans
 

 

March 5, 2009

BC Hydro launches second phase of Bioenergy Call for Power
 

 

March 3, 2009

Zymeworks Scientist Publishes in Noted Journal
 

 

March 3, 2009

StarFish Acquires Assets from ViVitro
 

 

March 2, 2009

ANGIOTECH PHARMACEUTICALS, INC. ANNOUNCES NEW SENIOR SECURED TERM LOAN AND CREDIT FACILITIES
 

 

March 2, 2009

EnWave Successfully Commercializes nutraREVTM Food Dehydration Technology
EnWave Corporation (TSX-V: ENW) (“EnWave” or “the Company”) today announced that it has completed the first sale of its continuous nutraREVâ„¢ food dehydration equipment to CAL-SAN Enterprises, Ltd. of Richmond, B.C. (“CAL-SAN”), one of B.C.’s largest blueberry producers. With this sale, EnWave has proven that it can produce shelf-stable, “puffed” blueberries on a commercial scale over a full operating shift. CAL-SAN has now completed the purchase of this technology, and has entered into a licencing and royalty agreement with EnWave.

 

February 26, 2009

Urodynamix Technologies Ltd. Receives CE Mark MMS to Launch UroNIRS 2000(TM) Bladder Monitor System at the Annual EAU in Stockholm Sweden
 

 

February 26, 2009

ANGIOTECH RECEIVES APPROVAL FOR QUILLâ„¢ SRS PDO, MONODERMâ„¢ AND NYLON PRODUCT LINES FOR SALE IN CANADA
 

 

February 25, 2009

SDTC Calls for Applications to its SD Tech Fund
 

 

February 19, 2009

iCo Therapeutics iCo-007 Results to be Presented at Prestigious Ocular Conference
VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce that early results for iCo’s Diabetic Macular Edema (DME) candidate, iCo-007, will be highlighted in a presentation at a prominent ocular conference.

 

February 19, 2009

Dr. Donald Rix to be Honoured by Research Chair
 

 

February 19, 2009

$1.4 Million Initiative for B.C.’s Agriculture, Food and Bioproducts Sectors
 

 

February 18, 2009

iCo Therapeutics Oral Amphotericin B Published in Leading Journal

VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce that a manuscript discussing iCo’s oral Amphotericin B (AmpB) formulation (“iCo-009”) has been published in a leading journal, the “International Journal of Pharmaceutics”. The paper illustrates iCo-009’s pronounced anti-fungal activity against Aspergillus fumigatus or Candida albicans, two potentially lethal fungal infections.

 

February 17, 2009

B.C.-Led PROOF Centre for Excellence Partners With Pfizer Canada in Fight Against Vital Organ Failure
 

 

February 17, 2009

Tekmira Partner Alnylam Presents Data on Programs Using Tekmira’s SNALP Technology at Keystone Meeting
 

 

February 9, 2009

iCo Therapeutics Closes $1.3 Million Private Placement

VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce the completion of a $1,292,500 non-brokered private placement. This financing provides the company with sufficient capital to develop iCo-007 through to the completion of the Phase 1 clinical trial. iCo-007 is targeting the treatment of Diabetic Macular Edema.   The balance of funds will provide the company with additional working capital.   iCo’s partner Isis Pharmaceuticals Inc., (NASDAQ: ISIS), participated as a lead investor in the financing, along with select insiders and existing shareholders.

 

February 9, 2009

PFIZER INCREASES FINANCIAL SUPPORT FOR BC-BASED INNOVATION THROUGH THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT
 

 

February 6, 2009

Biolux Research Announces ISO 13485 Quality System Certification and CE Mark Regulatory Approval of the OsseoPulseâ„¢ Bone Regeneration System.
 

 

February 6, 2009

$5 Million Strengthens British Columbia’s Clean Energy Leadership
 

 

February 5, 2009

ANGIOTECH’S CORPORATE PARTNER, BOSTON SCIENTIFIC, SUBMITS FINAL MODULES TO FDA FOR APPROVAL OF SECOND-GENERATION SMALL VESSEL AND LONG LESION STENTS
 

 

February 2, 2009

Breast cancer survival predicted by new Canadian tool
 

 

February 2, 2009

Using Nature’s Antibiotics to Coat Medical Devices
 

 

January 30, 2009

iCo Therapeutics Closes First Tranche of Non-Brokered Private Placement
 

 

January 29, 2009

ANGIOTECH’S CORPORATE PARTNER, BOSTON SCIENTIFIC, ANNOUNCES JAPANESE APPROVAL FOR TAXUS ® LIBERTÉ ® DRUG-ELUTING STENT SYSTEM
 

 

January 27, 2009

AURP Canada Applauds Federal Budget
 

 

January 26, 2009

Leading Biotech and Pharma Companies from Across the World to Meet in Vancouver, Canada for the 7th Annual BioPartnering North America Conference
 

 

January 23, 2009

New research will help predict potentially fatal adverse reactions to specific children’s drugs
 

 

January 22, 2009

Government of Canada Investment in Forestry, Pulp and Paper Technology
 

 

January 22, 2009

Heart Force Medical Appoints New President and CEO
 

 

January 16, 2009

Independent Trial of AFX Produces Excellent Results
 

 

January 15, 2009

BIOTECanada Calls for Government to Listen to Canadians, Support Innovation Industries
 

 

January 15, 2009

Brain Research Max Cynader Among UBC Members to Receive Canada’s Top Honour
 

 

January 12, 2009

Vancouver Island Technology Park Selected to Join Microsoft Bizspark Program
 

 

January 12, 2009

Allon Therapeutics Announces Milestones for 2009
 

 

January 9, 2009

Welichem Announces Appointment of New CFO
 

 

January 7, 2009

Forbes Medi-Tech Receives Extension to Compliance Deadline
 

 

January 7, 2009

UBC Researchers Discover Gene Mutation that Causes Eye Cancer
 

 

January 7, 2009

Tekmira Partner Alnylam Files First IND For An RNAi Therapeutic Utilizing SNALP
 

 

January 7, 2009

Pyng Medical Licenses Worldwide Rights to Emergency Surgical Airway Trainer
 

 

January 6, 2009

Urodynamix Technologies Ltd. Receives FDA 510(k) Clearance For UroNIRS 2000 Bladder Monitor System